Biomimetic approach to dental implants

Current Pharmaceutical Design

Volumn 14, Issue 22, 2008, Pages 2201-2211

  Kim, Tae Il ^a   Jang, Jun Hyeog ^b   Kim, Hae Won ^c   Knowles, Jonathan C ^d   Ku, Young ^a  

^a Seoul National University   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c Dankook University   (South Korea)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Biomimetic; Dental implant; Extracellular matrix; Osseointegration; Titanium

Indexed keywords

ALPHAVBETA5 INTEGRIN; ARGINYLGLYCYLASPARTIC ACID; BONE MORPHOGENETIC PROTEIN; BONE SIALOPROTEIN; COLLAGEN; DECORIN; FIBRONECTIN; GROWTH FACTOR; LAMININ; OSTEOPONTIN; TITANIUM; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN; VITRONECTIN RECEPTOR;

BIOCOMPATIBILITY; BIOMECHANICS; BIOMIMETICS; BONE DEFECT; BONE MINERALIZATION; BONE PROSTHESIS; BONE REGENERATION; CELL DIFFERENTIATION; CELL INTERACTION; EDENTULOUSNESS; ENDODONTICS; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; OSTEOBLAST; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROSTHESIS MATERIAL; PROTEIN EXPRESSION; PROTEIN STABILITY; REVIEW; TOOTH IMPLANTATION; TOOTH PROSTHESIS; TREATMENT OUTCOME; WOUND HEALING;

BIOMIMETICS; CELL ADHESION MOLECULES; DENTAL IMPLANTS; EXTRACELLULAR MATRIX PROTEINS; HUMANS;

EID: 52949099141     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208785740171     Document Type: Review

References (87)

1. Davarpanah M, Martinez H, Tecucianu JF, Fromentin O, Celletti R. To conserve or implant: which choice of therapy? Int J Periodontics Restorative Dent 2000; 20: 412-22.
2. Oshida Y, In: Oshida Y, Ed, Bioscience and bioengineering of titanium materials. Oxford, Elsevier 2007; 159-214.
3. Iacono VJ; Committee on Research, Science and Therapy, the American Academy of Periodentology. Dental implants in periodontal therapy. J Periodontol 2000; 71:1934-42.
4. Binon PP. Implants and components: entering the new millennium. Int J Oral Maxillofac Implants 2000; 15: 76-94.
5. Brånemark PI, Svensson B, van Steenberghe D. Ten-year survival rates of fixed prostheses on four or six implants ad modum Brånemark in fall edentulism. Clin Oral Implants Res 1995; 6: 227-31.
6. Schneider GB, Zaharias R, Seabold D, Keller J, Stanford C. Differentiation of preosteoblasts is affected by implant surface microtopographies. J Biomed Mater Res A 2004; 69: 462-8.
7. Leimola-Virtanen R, Peltola J, Oksala E, Helenius H, Happonen RP. ITI titanium plasma-sprayed screw implants in the treatment of edentulous mandibles: a follow-up Study of 39 patients. Int J Oral Maxillofac Implants 1995; 10: 373-8.
8. Gross KA, Berndt CC, Iacono VJ. Variability of hydroxyapatite-coated dental implants. Int J Oral Maxillofac Implants 1998; 13: 601-10.
9. Block MS, Finger IM, Fontenot MG, Kent JN. Loaded hydroxylapatite-coated, and grit-blasted titanium implants in dogs. Int J Oral Maxillofac Implants, 1989; 4: 219-25.
10. Buser D, Nydegger T, Hirt HP, Cochran DL, Nolte LP. Removal torque values of titanium implants in the maxilla of miniature pigs. Int J Oral Maxillofac Implants 1998; 13: 611-9.
11. Urist MR, Silverman BF, Büring K, Dubuc FL, Rosenberg JM. The bone induction principle. Clin Orthop Relat Res 1967; 53: 243-83.
12. Brånemark PI, Adell R, Breine U, Hansson BO, Lindström J, Ohlsson A. Intra-osseous anchorage of dental prostheses. I. Experimental studies. Scand J Plast Reconstr Surg 1969; 3: 81-100.
13. Bränemark PI, Hansson BO, Adell R, Breine U, Lindström J, Hallén O, et al. Osseointegrated implants in the treatment of the edentulous jaw. Experience from a 10-year period. Scand J Plast Reconstr Surg Suppl 1977; 16: 1-132.
14. Douglass CW, Watson AJ. Future needs for fixed and removable partial dentures in the United States. J Prosthet Dent 2002; 87: 9-14.
15. Douglass CW, Shih A, Ostry L. Will there be a need for complete dentures in the United States in 2020? J Prosthet Dent 2002; 87: 5-8.
16. Davies JE, Park JY. In: Ellingsen JE, Lyngstadaas SP Ed, Bioimplant interface: improving biomaterials and tissue reactions. Boca Raton, CRC Press LLC, 2003; 219-28.
17. Davies JE, Understanding peri-implant endosseous healing J Dent Educ 2003; 67: 932-49.
18. Mordohai N, Reshad M, Jivraj SA. To extract or not to extract? Factors that affect individual tooth prognosis. J Calif Dent Assoc 2005; 33: 319-28.
19. Cooper LF, Deporter D, Wennerberg A, Hämmerle C. What physical and/ or biochemical characteristics of roughened endosseous implant surfaces particularly enhance their bone-implant contact capability? Int J Oral Maxillofac Implants 2005; 20: 307-12.
20. Schroeder A, van der Zypen E, Stich H, Sutter F. The reactions of bone, connective tissue, and epithelium to endosteal implants with titanium-sprayed surfaces. J Maxillofac Surg 1981; 9: 15-25.
21. Suzawa M, Tamura Y, Fukumoto S, Miyazono K, Fujita T, Kato S, et al. Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: a possible mechanism for collagen-dependent osteoblastic differentiation. J Bone Miner Res 2002; 17: 240-8.
22. Wennerberg A, Albrektsson T, Andersson B. Design and surface characteristics of 13 commercially available oral implant systems. Int J Oral Maxillofac Implants 1993; 8: 622-33.
23. Gallucci GO, Belser UC, Bernard JP, Magne P. Modeling and characterization of the CEJ for optimization of esthetic implant design. Int J Periodontics Restorative Dent 2004; 24: 19-29.
24. Lin S, Shi S, LeGeros RZ, LeGeros JP. Three-dimensional finite element analyses of four designs of a high-strength silicon nitride implant. Implant Dent 2000; 9: 53-60.
25. Sul YT. The sipificance of the surface properties of oxidized titanium to the bone response: special emphasis on potential biochemical bonding of oxidized titanium implant. Biomaterials 2003; 24: 3893-907.
26. Deligianni DD, Katsala N, Ladas S, Sotiropoulou D, Amedee J, Missirlis YF. Effect of surface roughness of the titanium alloy Ti-6A1-4V on human bone marrow cell response and on protein adsorption. Biomaterials 2001; 22: 1241-51.
27. Ito K, Namba K, Nishida T, Sato H, Murai S. Comparison of osseointegration between hydroxyapatite-coated and uncoated threaded titanium dental implants placed into surgically-created bone defect in rabbit tibia. J Oral Sci 1998; 40; 37-41.
28. Karoussis IK, Brägger U, Salvi GE, Bürgin W, Lang NP. Effect of implant design on survival and success rates of titanium oral implants: a 10-year prospective cohort study of the ITI Dental Implant System. Clin Oral Implants Res 2004; 15: 8-17.
29. Kantlehner M, Schaffner P, Finsinger D, Meyer J, Jonczyk A, Diefenbach B, et al. Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem 2000; 1: 107-14.
30. Damsky CH. Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling. Bone 1999; 25: 95-6.
31. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002; 2: 91-100.
32. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491-7.
33. Moradian-Oldak J, Wen HB, Schneider GB, Stanford CM. Tissue engineering strategies for the future generation of dental implants. Periodontol 2000 2006; 41: 157-76.
34. Schaffner P, Dard MM. Structure and function of RGD peptides involved in bone biology. Cell Mol Life Sci 2003; 60: 119-32.
35. Rezania A, Healy KE. Integrin subunits responsible for adhesion of human osteoblast-like cells to biomimetic peptide surfaces. J Orthop Res 1999; 17: 615-23.
36. Itoh D, Yoneda S, Kuroda S, Kondo H, Umezawa A, Ohya, K, et al. Enhancement of osteogenesis on hydroxyapatite surface coated with synthetic peptide (EEEEEEEPRGDT) in vitro. J Biomed Mater Res 2002; 62: 292-8.
37. Puleo DA, Bizios R. RGDS tetrapeptide binds to osteoblasts and inhibits fibronectin-mediated adhesion. Bone 1991; 12: 271-6.
38. Moursi AM, Globus RK, Damsky CH. Interations between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. J Cell Sci 1997; 110: 2187-96.
39. Robey PG. Vertebrate mineralized matrix proteins: structure and function. Connect Tissue Res 1996; 35: 131-6.
40. Blancher C, Omri B, Bidou L, Pessac B, Crisanti P. Nectinepsin: a new extracellular matrix protein of the pexin family. Characterization of a novel cDNA encoding a protein with an RGD cell binding motif. J Biol Chem 1996; 271: 26220-6.
41. Chipperfield H, Bedi KS, Cool SM, Nurcombe V. Heparan sulfates isolated from adult neural progenitor cells can direct phenotypic maturation. Int J Dev Biol 2002; 46: 661-70.
42. Raouf A, Ganss B, McMahon C, Vary C, Roughley PJ, Seth A. Lumican is a major proteoglycan component of the bone matrix. Matrix Biol 2002; 21; 361-7.
43. Oshida Y, In: Oshida Y. Ed, Bioscience and bioengineering of titanium materials. Oxford, Elsevier 2007; 217-53.
44. Boskey AL. In: Hollinger JO, Einhorn TA, Doll BA, Sfeir C Eds, Bone tissue engineering. Boca Raton, CRC Press, 2005; 91-123.
45. Geissler U, Hempel U, Wolf C, Scharnweber D, Worch H, Wenzel K. Collagen type I-coating of Ti6A14V promotes adhesion of osteoblasts. J Biomed Mater Res 2000; 51: 752-60.
46. Roehlecke C, Witt M, Kasper M, Schulze E, Wolf C, Hofer A, et al. Synergistic effect of titanium alloy and collagen type I on cell adhesion, proliferation and differentiation of osteoblast-like cells, Cells Tissues Organs 2001; 168: 178-87.
47. Morra M, Cassinelli C, Cascardo G, Cahalan P, Cahalan L, Fini M, et al. Surface engineering of titanium by collagen immobilization. Surface characterization and in vitro and in vivo studies. Biomaterials 2003; 24: 4639-54.
48. Morra M, Cassinelli C, Fini M, Giardino R. Enhanced osteointegration by biochemical surface modification: covalent linking of collagen I to intervertebral metal disk surface. Eur Cell Mater 2005; 10(Suppl 3): 6.
49. Morra M, Cassinelli C, Cascardo G, Mazzucco L, Borzini P, Fini M, et al. Collagen I-coated titanium surfaces: mesenchymal cell adhesion and in vivo evaluation in trabecular bone implants. J Biomed Mater Res A 2006; 78: 449-58.
50. Rammelt S, Schulze E, Bernhardt. R, Hanisch U, Scharnweber D, Worch H, et al. Coating of titanium implants with type-I collagen. J Orthop Res 2004; 22: 1025-34.
51. Kim HW, Li LH, Lee EJ, Lee SH, Kim HE, Fibrillar assembly and stability of collagen coating on titanium for improved osteoblast responses. J Biomed Mater Res A 2005; 75: 629-38.
52. García AJ, Ducheyne P, Boettiger D. Effect of surface reaction stage on fibronectin-mediated adhesion of osteoblast-like cells to bioactive glass. J Biomed Mater Res 1998; 40: 48-56.
53. Couchourel D, Escoffier C, Rohanizadeh R, Bohic S, Daculsi G, Fortun Y, et al. Effects of fibronectin on hydroxyapatite formation. J Inorg Biochem 1999; 73: 129-36.
54. Petrie TA, Raynor JE, Reyes CD, Burns KL, Collard DM, García AJ. The effect of integrin-specific bioactive coatings on tissue healing and implant osseointegration. Biomaterials 2008; 29: 2849-57.
55. Wuttke M, Müller S, Nitsche DP, Paulsson M, Hanisch FG, Maurer P. Structural characterization of human recombinant and bone-derived bone sialoprotein. Functional implications for cell attachment and hydroxyapatite binding. J Biol Chem 2001; 276: 36839-48.
56. O'Toole GC, Salih E, Gallagher C, FitzPAtrick D, O'Higgins N, O'Rourke, SK. Bone sialoprotein-coated femoral implants are osteoinductive but mechanically compromised. J Orthop Res 2004; 22: 641-6.
57. Birbaum S, Douglas T, Hanke T, Scharnweber D, Tippelt S, Monsees TK, et al. Collageneous matrix coatings on titanium implants modified with decorin and chondroitin sulfate: characterization and influence on osteoblastic cells. J Biomed Mater Res A 2006; 77: 551-62.
58. Fischer JW, Steitz SA, Johnson PY, Burke A, Kolodgie F, Virmani R, et al. Decorin promotes aortic smooth muscle cell calcification and colocalizes to calcified regions in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2004; 24: 2391-6.
59. Kamiya N, Shigemasa K, Takagi M. Gene expression and immunohistochemical localization of decorin and biglycan in association with early bone formation in the developing mandible. J Oral Sci 2001; 43: 179-88.
60. Waddington RJ, Roberts HC, Sugars RV, Schönherr E. Differential roles for small leucine-rich proteoglycans in bone formation. Eur Cell Mater 2003; 6: 12-21.
61. Witt DP, Lander AD. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biol 1994; 4: 394-400.
62. Zamfir A, Seidler DG, Kresse H, Peter-Katalinić J. Structural investigation of chondroitin/dermatan sulfate oligosaccharides from human skin fibroblast decorin. Glycobiology 2003; 13: 733-42.
63. Kim TI, Chung CP, Ku Y. The effect of bioactive molecule coated titanium implant on in-vivo study. Proc Asian Bioceram Symp 2005; 5: 372-5.
64. Henry PJ, Tan AE, Leavy J, Johansson CB, Albrektsson T. Tissue regeneration in bony defects adjacent to immediately loaded titanium implants placed into extraction sockets: a study in dogs. Int J Oral Maxillofac Implants 1997; 12: 758-66.
65. Pham MT, Reuther H, Maitz MF. Native extracellular matrix coating on Ti surfaces. J Biomed Mater Res A 2003; 66: 310-6.
66. Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984; 309: 30-3.
67. Kim TI, Jang JH, Chung CP, Ku Y. Fibronectin fragment promotes osteoblast-associated gene expression and biological activity of human osteoblast-like cell. Biotechnol Lett 2003; 25: 2007-11.
68. Kim TI, Lee G, Jang JH, Chung CP, Ku Y. Influence of RGD-containing oligopeptide-coated surface on bone formation in vitro and in vivo. Biotechnol Lett 2007; 29: 359-63.
69. Dettin M, Conconi MT, Gambaretto R, Pasquato A, Folin M, Di Bello C, et al. Novel osteoblast-adhesive peptides for dental/orthopedic biomaterials. J Biomed Mater Res 2002; 60: 466-71.
70. Rezania A, Thomas CH, Branger AB, Waters CM, Healy KE. The detachment strength and morphology of bone cells contacting materials modified with a peptide sequence found within bone sialoprotein. J Biomed Mater Res 1997; 37: 9-19.
71. Reyes CD, García AJ. Engineering integrin-specific surfaces with a triple-helical collagen-mimetic peptide. J Biomed Mater Res A 2003: 65: 511-23.
72. Healy KE, Rezania A, Stile RA. Designing biomaterials to direct biological responses. Ann N Y Acad Sci 1999; 875: 24-35.
73. Rezania A, Healy KE. Biomimetic peptide surfaces that regulate adhesion, spreading, cytoskeletal organization, and mineralization of the matrix deposited by osteoblast-like cells. Biotechnol Prog 1999; 15: 19-32.
74. Dee KC, Bizios R. Mini-review: Proactive biomaterials and bone tissue engineering. Biotechnol Bioeng 1996; 50: 438-42.
75. Qian JJ, Bhatnagar RS. Enhanced cell attachment to anorganic bone mineral in the presence of a synthetic peptide related to collagen. J Biomed Mater Res 1996; 31: 545-54.
76. Cheng SL, Lai CF, Blystone SD, Avioli LV. Bone mineralization and osteoblast differentiation are negatively modulated by integrin alpha(v)beta3. J Bone Miner Res 2001; 16: 277-88.
77. Bagno A, Piovan A, Dettin M, Chiarion A, Brun P, Gambaretto R, et al. Human osteoblast-like cell adhesion on titanium substrates covalently functionalized with synthetic peptides. Bone 2007; 40: 693-9.
78. Vukicevic S, Luyten FP, Kleinman HK, Reddi AH. Differentiation of canalicular cell processes in bone cells by basement membrane matrix components: regulation by discrete domains of laminin. Cell 1990; 63: 437-45.
79. Aota S, Nagai T, Yamada KM. Characterization of regions of fibronectin besides the arginine-glycine-aspartic acid sequence required for adhesive function of the cell-binding domain using site-directed mutagenesis. J Biol Chem 1991; 266: 15938-43.
80. McCann TJ, Terranova G, Keyte JW, Papaioannou SS, Mason WT, Meikle MC, et al. An analysis of Ca2+ release by DGEA: mobilization of two functionally distinct internal stores in Saos-2 cells. Am J Physiol 1998; 275: C33-41.
81. Marukawa E, Asahina J, Oda M, Seto I, Alam M, Enomoto S. Functional reconstruction of the non-human primate mandible using recombinant human bone morphogenetic protein-2. Int J Oral Maxillofac Surg 2002; 31: 287-95.
82. Fiorellini JP, Buser D, Riley E, Howell TH. Effect on bone healing of bone morphogenetic protein placed in combination with endosseous implants: a pilot study in beagle dogs. Int J Periodontics Restorative Dent 2001; 21: 41-7.
83. Kawaguchi H, Nakamura K, Tabata Y, Ikada Y, Aoyama I, Anzai J, et al. Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J Clin Endocrinol Metab 2001; 86: 875-80.
84. Jang JH, Ku Y, Chung CP, Heo SJ. Enhanced fibronectin-mediated cell adhesion of human osteoblast by fibroblast growth factor, FGF-2. Biotechnol Lett 2002; 24: 1659-63.
85. Jandeleit-Dahm K, Cooper ME. The role of AGEs in cardiovascular disease. Curr Pharm Des 2008; 14(10): 979-86.
86. Sugimoto K, Yasujima M, Yagihashi S. Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des 2008; 14(10): 953-61.
87. Tu G, Xu W, Huang H, Li S. Progress in the development of matrix metalloproteinase inhibitors. Curr Med Chem 2008; 15(14): 1388-95.